Moreover, in another study, AKT1 and other kinases were detected in blood EVs from patients with various epithelial tumor types, which has implications for metastatic prostate cancer due to genomic abnormalities in the PI3K pathway, though the distinction between large and small EVs was not made (Minciacchi et al, 2017). Here, AKT1 is linked to prostate carcinoma.